CMPS

Psychedelic Medicine Advances: Here Are Five Companies Targeting CNS Disorders

02/26 01:07 pm

Why Did Compass Pathways Stock Rocket Higher Today?

02/17 12:35 pm

Why Compass Pathways Stock Was a Double-Digit Winner This Week

04/25 06:13 pm

Comprehensive Market Analysis of Latest Published Different Types of Depression Reports | DelveInsight

02/25 02:00 pm

Compass Pathways to participate in three investor conferences in September

08/28 06:00 am

4 Psychedelic Stocks to Consider as Clinical Trials Heat up

08/06 03:13 pm

Compass Pathways initiated at 'Outperform' by RBC, cites $2.3B revenue potential - Investing.com

07/23 04:38 am

Compass Pathways appoints Lori Englebert as Chief Commercial Officer

06/26 06:30 am

Should You Buy the Dip on Compass Pathways Stock?

06/12 06:25 am

Psychedelics Stocks Are Falling After a Shocking Vote at the FDA. Here's What You Need to Know.

06/10 08:25 am

These 2 Catalysts Could Soon Send Compass Pathways Stock Soaring

05/21 08:05 am

Compass Pathways Plc (CMPS) Q1 2024 Earnings Call Transcript

05/09 04:45 am

Compass Pathways Announces First Quarter 2024 Financial Results and Business Highlights

05/08 06:45 am

Compass Pathways announces durable improvement in symptoms through 12 weeks in open-label phase 2 study of COMP360 psilocybin in post-traumatic stress disorder

05/08 06:30 am

Compass Pathways to announce first quarter financial results on May 8, 2024

05/03 04:58 pm

Compass Pathways establishes research collaboration with Mindful Health Solutions to inform the development of a scalable and cost-effective delivery model for investigational COMP360 psilocybin treatment

05/02 06:30 am

Compass Pathways and Journey Clinical establish research collaboration agreement to inform the training of healthcare providers and delivery model for COMP360 psilocybin treatment, if approved for treatment-resistant depression

04/29 06:30 am

Compass Pathways to participate in upcoming 23rd Annual Needham Virtual Healthcare Conference

04/01 04:01 pm

Micron, Iris Energy, Trip.com Group And Other Big Stocks Moving Higher On Monday

04/01 01:02 pm

Compass Pathways Board Chair and Co-Founder George Goldsmith and Co-Founder Ekaterina Malievskaia Step Down from Board of Directors

03/28 08:00 am

MindMed’s stock soars 51.5% after FDA grants breakthrough designation to LSD therapy for a form of anxiety

03/08 09:40 am

3 Biopharma Stocks You Don't Want to Miss in the New Bull Market

03/05 10:30 am

Compass Pathways Plc (CMPS) Q4 2023 Earnings Call Transcript

02/29 04:30 pm

Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

02/29 03:00 pm

Compass Pathways Announces Fourth Quarter 2023 Financial Results and Business Highlights 

02/29 08:00 am

Compass Pathways to participate in upcoming TD Cowen investor conference

02/26 05:01 pm

Compass Pathways to announce fourth quarter and year-end 2023 financial results on February 29, 2024

02/22 05:01 pm

Wall Street Says Compass Pathways Could Rise 307%. Here's How It Could Actually Happen.

02/19 08:00 am

Compass Pathways to participate in upcoming Oppenheimer investor conference

01/31 05:01 pm

Compass Pathways enters into research collaboration agreement with Hackensack Meridian Health to develop optimal clinical model for investigational COMP360 psilocybin treatment, if FDA-approved

01/16 09:00 am

3 Big New Catalysts for Psychedelics Stocks in 2024

01/08 12:47 pm

One backer of MDMA therapy sees 'exponential' growth upon FDA approval this year

01/03 12:17 pm

Compass Pathways announces investigational COMP360 psilocybin treatment was well-tolerated in phase 2 study of post-traumatic stress disorder

12/19 05:05 pm

MindMed’s stock boosted by positive data in trial of LSD as treatment for anxiety disorder

12/14 01:39 pm

Study results of psilocybin treatment in bipolar II depression published in JAMA Psychiatry

12/06 05:00 pm

La-Z-Boy Posts Upbeat Earnings, Joins Victoria's Secret, Snowflake And Other Big Stocks Moving Higher On Thursday

11/30 11:12 am

Compass Pathways to participate in upcoming Evercore investor conference

11/24 09:00 am

Compass Pathways initiates UK component of global phase 3 study of psilocybin treatment in treatment-resistant depression and launches new research center

11/15 05:00 am

Azenta Reports Upbeat Earnings, Joins Talis Biomedical, Sally Beauty And Other Big Stocks Moving Higher On Tuesday

11/14 11:39 am

Compass Pathways Plc (CMPS) Q3 2023 Earnings Call Transcript

11/03 11:39 am

COMPASS Pathways Announces Third Quarter 2023 Financial Results and Business Highlights

11/02 07:00 am

COMPASS Pathways announces CFO transition

10/26 08:00 am

COMPASS Pathways appoints Daphne Karydas to its Board of Directors

09/18 04:31 pm

COMPASS Pathways PLC Sponsored ADR (CMPS) Just Flashed Golden Cross Signal: Do You Buy?

09/08 09:55 am

COMPASS Pathways announces publication of first study evaluating potential of AI model to predict outcomes of COMP360 psilocybin treatment in treatment-resistant depression

09/06 04:00 am

COMPASS Pathways to participate in upcoming September investor conferences

08/29 04:30 pm

3 Cathie Wood Stocks With Parabolic Growth Potential, According to Wall Street

08/26 07:50 am

The Latest Analyst Ratings for Compass Pathways

08/22 10:00 am

Compass Pathways Plc (CMPS) Q2 2023 Earnings Call Transcript

08/04 12:00 am

COMPASS Pathways Announces Second Quarter 2023 Financial Results and Business Highlights  

08/03 07:00 am